Über Website:

Domänenname - prometa.de

Seitentitel - infotraX: Ihr Spezialist für individualisierbare Softwarelösungen

Domain prometa.de wird umgeleitet https://www.infotrax.de/

GEO-Standort der Website

Standort Land - Germany

Anbieter - Hetzner Online GmbH

Site Logo

IP Adresse:

185.189.228.180

Domain-Name-Server:

f2.de.ha-dns.net lxa.us.ha-dns.net m.de.ha-dns.net ka2.de.ha-dns.net

Alle Aufzeichnungen:

☆ prometa.de. 14396 IN A 185.189.228.180
☆ prometa.de. 14396 IN MX 100 mx1a.fritz.gmbh.
☆ prometa.de. 14396 IN MX 100 mx1b.fritz.gmbh.
☆ prometa.de. 14396 IN NS f2.de.ha-dns.net.
☆ prometa.de. 14396 IN NS m.de.ha-dns.net.
☆ prometa.de. 14396 IN NS ka2.de.ha-dns.net.
☆ prometa.de. 14396 IN NS lxa.us.ha-dns.net.
☆ prometa.de. 14396 IN TXT "v=spf1 include:spf.fritz.gmbh -all"
☆ prometa.de. 14396 IN SOA m.de.ha-dns.net. do-not-reply.prometa.de. 2024052300 39940 14400 604800 14400

%
% Terms and Conditions of Use
%
% The above data may only be used within the scope of technical or
% administrative necessities of Internet operation or to remedy legal
% problems.
% The use for other purposes, in particular for advertising, is not permitted.
%
% The DENIC whois service on port 43 doesn't disclose any information concerning
% the domain holder, general request and abuse contact.
% This information can be obtained through use of our web-based whois service
% available at the DENIC website:
% http://www.denic.de/en/domains/whois-service/web-whois.html
%
%

Domain: prometa.de
Nserver: f2.de.ha-dns.net
Nserver: ka2.de.ha-dns.net
Nserver: lxa.us.ha-dns.net
Nserver: m.de.ha-dns.net
Status: connect
Changed: 2024-03-20T09:06:20+01:00

Brief facts about prometa:

Prometa is an ineffective treatment promoted for methamphetamine addiction, although it had also been claimed to be effective for dependence on alcohol or cocaine. It was marketed as GABASYNC. The treatment, based loosely on the research of Spanish psychologist Juan Jose Legarda, involved a combination of three medications as well as therapy. While the individual drugs had been approved by the FDA, their off-label use for addiction treatment has not.. Prometa was marketed by Hythiam, Inc. which is owned by Terren Peizer, a former junk bond trader. Hythiam has sought to patent the protocol and charges up to $15,000 per patient to license its use. Lower rates are offered to the criminal justice system, where it has been used in several drug court pilot programs. In November 2011, the results of a double-blind, placebo-controlled study were published in the peer-reviewed journal Addiction.

Substance dependence

Alcohol abuse

Drug rehabilitation